Cox proportional hazards regression in small studies of predictive biomarkers by Jóźwiak, K., Nguyen, V. H., Sollfrank, L., Linn, S. C., Hauptmann, M.

Get full text

Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre tria... by van Roozendaal, L M, Vane, M L G, van Dalen, T, van der Hage, J A, Strobbe, L J A, Boersma, L J, Linn, S C, Lobbes, M B I, Poortmans, P M P, Tjan-Heijnen, V C G, Van de Vijver, K K B T, de Vries, J, Westenberg, A H, Kessels, A G H, de Wilt, J H W, Smidt, M L

Get full text

A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer by Sollfrank, L, Linn, S C, Hauptmann, M, Jóźwiak, K

Get full text

A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study by Drukker, C.A., Bueno‐de‐Mesquita, J.M., Retèl, V.P., Harten, W.H., Tinteren, H., Wesseling, J., Roumen, R.M.H., Knauer, M., Veer, L.J., Sonke, G.S., Rutgers, E.J.T., Vijver, M.J., Linn, S.C.

Get full text

A real or apparent decrease in glomerular filtration rate in patients using olaparib? by Bruin, M. A. C., Korse, C. M., van Wijnen, B., de Jong, V. M. T., Linn, S. C., van Triest, B., Rosing, H., Beijnen, J. H., van den Broek, D., Huitema, A. D. R.

Get full text

Correction: A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer by Sollfrank, L, Linn, SC, Hauptmann, M, Jóźwiak, K

Get full text

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature by Opdam, M., van der Noort, V., Kleijn, M., Glas, A., Mandjes, I., Kleiterp, S., Hilbers, F. S., Kruger, D. T., Bins, A. D., de Jong, P. C., Schiphorst, P. P. J. B. M., van Dalen, T., Flameling, B., Rietbroek, R. C., Beeker, A., van den Heiligenberg, S. M., Bakker, S. D., Wymenga, A. N. M., Oving, I. M., Bijlsma, R. M., van Diest, P. J., Vermorken, J. B., van Tinteren, H., Linn, S. C.

Get full text

The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07) by van Roozendaal, L M, de Wilt, J H W, van Dalen, T, van der Hage, J A, Strobbe, L J A, Boersma, L J, Linn, S C, Lobbes, M B I, Poortmans, P M P, Tjan-Heijnen, V C G, Van de Vijver, K K B T, de Vries, J, Westenberg, A H, Kessels, A G H, Smidt, M L

Get full text

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy by Straver, M. E., Rutgers, E. J. Th, Rodenhuis, S., Linn, S. C., Loo, C. E., Wesseling, J., Russell, N. S., Oldenburg, H. S. A., Antonini, N., Vrancken Peeters, M. T. F. D.

Get full text

Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in de... by de Maar, Josanne S, Suelmann, Britt B M, Braat, Manon N G J A, van Diest, P J, Vaessen, H H B, Witkamp, Arjen J, Linn, S C, Moonen, Chrit T W, van der Wall, Elsken, Deckers, Roel

Get full text

Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: A multicentre, open-label, randomis... by Lam, S.W, de Groot, S.M, Honkoop, A.H, Jager, A, ten Tije, A.J, Bos, M.M.E.M, Linn, S.C, van den Bosch, J, Kroep, J.R, Braun, J.J, van Tinteren, H, Boven, E

Get full text

Validation of 70-gene prognosis signature in node-negative breast cancer by Bueno-de-Mesquita, J. M, Linn, S. C, Keijzer, R, Wesseling, J, Nuyten, D. S. A, van Krimpen, C, Meijers, C, de Graaf, P. W, Bos, M. M. E. M, Hart, A. A. M, Rutgers, E. J. T, Peterse, J. L, Halfwerk, H, de Groot, R, Pronk, A, Floore, A. N, Glas, A. M, van't Veer, L. J, van de Vijver, M. J

Get full text

Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: A population-based cohort study by Dackus, G.M.H.E., Jóźwiak, K., Sonke, G.S., van der Wall, E., van Diest, P.J., Hauptmann, M., Siesling, S., Linn, S.C.

Get full text

Identification of a low-risk subgroup of HER-2-positive breast cancer by the 70-gene prognosis signature by Knauer, M, Cardoso, F, Wesseling, J, Bedard, P L, Linn, S C, Rutgers, E J T, van 't Veer, L J

Get full text

Prognostic factors for survival in metastatic breast cancer by hormone receptor status by Kwast, A. B. G., Voogd, A. C., Menke-Pluijmers, M. B. E., Linn, S. C., Sonke, G. S., Kiemeney, L. A., Siesling, S.

Get full text

Prospective cost-effectiveness analysis of genomic profiling in breast cancer by Retèl, V.P, Joore, M.A, Drukker, C.A, Bueno-de-Mesquita, J.M, Knauer, M, van Tinteren, H, Linn, S.C, van Harten, W.H

Get full text

Importance of highly selective LC–MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen by Jager, N. G. L., Rosing, H., Linn, S. C., Schellens, J. H. M., Beijnen, J. H.

Get full text

Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004... by van Rossum, A.G.J., Kok, M., van Werkhoven, E., Opdam, M., Mandjes, I.A.M., van Leeuwen – Stok, A.E., van Tinteren, H., Imholz, A.L.T., Portielje, J.E.A., Bos, M.M.E.M., van Bochove, A., Wesseling, J., Rutgers, E.J., Linn, S.C., Oosterkamp, H.M.

Get full text

Development and validation of a quantitative assay for the analysis of tamoxifen with its four main metabolites and the flavonoids daidzein, genistein and glycitein in human serum... by Teunissen, S.F., Rosing, H., Koornstra, R.H.T., Linn, S.C., Schellens, J.H.M., Schinkel, A.H., Beijnen, J.H.

Get full text

Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer by Rigter, L S, Loo, C E, Linn, S C, Sonke, G S, van Werkhoven, E, Lips, E H, Warnars, H A, Doll, P K, Bruining, A, Mandjes, I A, Vrancken Peeters, M J, Wesseling, J, Gilhuijs, K G, Rodenhuis, S

Get full text